Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY 10017, NDC 0009-0068-07.
Published May 18, 2022 · Recall initiated: April 28, 2022
Summary
FDA records drug Class II recall D-0854-2022, published May 18, 2022 and initiated April 28, 2022. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 110 bottles; Lot: Lot #: DX7983, exp. date 02/28/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: low out of specification results for dissolution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Viatris Inc
- Distributor
- Product was distributed nationwide in the USA
- Lot
- Lot #: DX7983, exp. date 02/28/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDALevothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b)December 18, 2024
- FDALevothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b)December 18, 2024
- FDAMVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, Single dose vial,May 18, 2022
- FDAK-Wire, 1.35 mm x 170 mmMay 11, 2022
Questions about this recall
Was Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY 10017, NDC 0009-0068-07. recalled?
Yes. FDA published recall D-0854-2022 on May 18, 2022. Reported hazard: Failed Dissolution Specifications: low out of specification results for dissolution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter